Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: A New WHO standard. Global Programme on Evidence Discussion Paper Series: No. 31. Geneva, WHO; 2000.
Akhtar-Danesh N, Elit L, Lytwyn A. Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992-2005: A population-based study. Gynecologic Oncology. 2011;123(2):192-195.
Aziz MF. Gynecological cancer in Indonesia. J Gynecol Oncol. 2009; 20 (1):8-10.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
Chan JK, Urban R, Cheung MK, Osann K, Shin JY, Husain A, et al. Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer 2006; 95:1314-20.
Chang LC, Huang CF, Lai MS, Shen LJ, Wun FLLL, Cheng WF. Prognostic factors in epithelial ovarian cancer: A population-based study. PLoS ONE. 2018;13(3): e0194993
Chiang YC, Chen CA, Chiang CJ, Hsu TH, Lin MC, You SL, et al. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. J Gynecol Oncol. 2013; 24 (4): 342-351.
Coburn, S. B., Bray, F., Sherman, M. E., & Trabert, B. (2017). International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. International Journal of Cancer, 140(11), 2451–2460. https://doi.org/10.1002/ijc.30676
Cristea M, Han E, Salmon L, Morgan RJ. Practical considerations in ovarian cancer chemotherapy. Therapeutic advances in medical oncology. 2010; 2(3): 175–187.
Department of Economic Planning and Statistics (DEPS), Ministry of Finance and Economy, Brunei Darussalam. Population. 2019. http://www.deps.gov.bn/SitePages/Population.aspx. Accessed 14 September 2021.
Department of Policy and Planning (DPP), Ministry of Health Brunei Darussalam. Health Information Booklet 2017. 2018. http://www.moh.gov.bn/Downloadables/Health%20Information%20Bookler%202017%20(revised%20as%20of%20January%202019).pdf Accessed 2 October 2021.
Department of Statistics (DOS), Department of Economic Planning and Statistics, Ministry of Finance and Economy, Brunei Darussalam. Population. Population by Age Group and Sex. eData Library. 2020. http://www.deps.gov.bn/SitePages/eData%20library.aspx Accessed 30 September 2021.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
Fritz A, Percy C, Jack A, Shanmugarathan S, Sobin L, Parkin D, et al. International classification of diseases for oncology (ICD-O) 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, et al. Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis. Oncology Letters. 2020; 19, 1947-1957.
Ishioka S, Sagae S, Ito E, Kudo R. Ultrastructural study of benign, low-malignant potential (LMP), and malignant ovarian tumors. Med Electron Microsc. 2004; 37:37–44.
Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO Classification of Tumours of the Female Reproductive Organs. Lyon: WHO Press; 2014.
Kurosaki A, Hasegawa K, Kato T, Abe K, Hanaoka T, Miyara A, et al. Serum folate receptor alpha as a biomarker for ovarian cancer: implications for diagnosis, prognosis and predicting its local tumor expression. Int J Cancer. 2016;138:1994–2002.
Lee JY, Kim S, Kim YT, Lim MC, Lee B, Jung KW, et al. Changes in ovarian cancer survival during the 20 years before the era of targeted therapy. BMC Cancer. 2018; 18: 601
Leong, E; Madli,F; Ong, SK (2019). FIVE-YEAR SURVIVAL RATE OF BREAST CANCER PATIENTS IN BRUNEI DARUSSALAM. Brunei International Medical Journal, 15, 73–81.
Liu H, Xu Y, Ji J, Dong R, Qiu H, Dai X. Prognosis of ovarian clear ell cancer compared with other epithelial cancer types: A population-based analysis. Oncology letters. 2020; 19: 1947-1957.
Lokman N, Hamid SAA, Bachok N. Survival study and prognostic factors of ovarian cancer registered in a teaching hospital in Malaysia. Sains Malaysiana. 2017; 46(4):559-565.
Madli F, Leong E, Ong SK, Lim E, Tengah KA. Predictive factors associated with survival rate of cervical cancer patients in Brunei Darussalam. Brunei Int Med J. 2019; 15: 125-132.
National Cancer Registry (NCR), National Cancer Institute, Ministry of Health, Malaysia. 2018. Malaysian Study on Cancer Survival (MySCan). https://www.moh.gov.my/moh/resources/Penerbitan/Laporan/Umum/Malaysian_Study_on_Cancer_Survival_MySCan_2018.pdf Accessed 27 May 2021.
National Registry of Diseases Office (NRDO). Singapore Cancer Registry Annual Report, National Registry of Diseases Office, Ministry of Health, Singapore. 2021. Cancer Survival in Singapore 1973 – 2012. https://www.nrdo.gov.sg/docs/librariesprovider3/default-document-library/scr-annual-report-2018.pdf?sfvrsn=bcf56c25_0 Accessed 2 Oct 2021.
Permuth-Wey J and Sellers TA. Epidemiology of ovarian cancer. Methods in Molecular Biology. 2009; 472 (4): 413-437.
Raja FA, Chopra N, Ledermann JA. Optimal first-line treatment in ovarian cancer. Annals of Oncology. 2012; 23, 118-127.
Razi S, Ghoncheh M, Mohammadian-Hafshejani A, Aziznejhad H, Mohammadian M, Salehiniya H. The incidence and mortality of ovarian cancer and their relationship with the Human Development Index in Asia. 2016; 10: 628.
Rohani-Rasaf M, Abdollahi M, Jazayeri S, Kalantari N, Asadi-Lari M. Correlation of cancer incidence with diet, smoking and socio- economic position across 22 districts of Tehran in 2008. Asian Pacific J Cancer Prev. 2013;14(3):1669–76.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowic CD, et al. Ovarian Cancer Statistics, 2018. CA Cancer J Clin. 2018; 68, 284-296.
UNDP. Human Development Report 2020. The Next Frontier: Human Development and the Anthropocene. Brunei Darussalam. 2020. http://hdr.undp.org/sites/default/files/Country-Profiles/BRN.pdf Accessed 21 September 2021
Verheijen R and Zweemer R. Screening to improve ovarian cancer prognosis?. The Lancet. 2016; 387: 921-922.
World Health Organization (WHO). International Agency for Research on Cancer. Global Cancer Observatory (GLOBOCAN). 2020a. Ovary [Fact sheet]. https://gco.iarc.fr/today/data/factsheets/cancers/25-Ovary-fact-sheet.pdf Accessed 1st April 2021.
World Health Organization (WHO). International Agency for Research on Cancer. Global Cancer Observatory (GLOBOCAN). 2020b. Brunei Darussalam [Fact Sheet]. https://gco.iarc.fr/today/data/factsheets/populations/96-brunei-darussalam-fact-sheets.pdf Accessed 16 September 2021.
Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlburt AA (eds). SEER Summary Staging Manual - 2000: Codes and Coding Instructions, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.